Evaluation of conjunctival hyperemia induced by Glanatec ophthalmic solution 0.4% - Evaluation of conjunctival hyperemia induced by Glanatec ophthalmic solution 0.4%(ROCKHY)

Kochi medical school hospital,ophthalmology0 个研究点目标入组 50 人开始时间: 2015年10月30日最近更新: 2023年10月17日

试验速览

暂无简介。

•1)Patients having hypersensitivity against ripasujiru hydrochloride hydrate, Anhydrous dihydrogen phosphate sodium, Glycerine, Sodium hydroxide, Dark benzalconium chloride liquid 50. 2)Less than -12 dB of the MD value 3)Regarding pregnant women, Women whose terms are closed to and Lactating women, benefit is superior to dangerousness. 4)Secondary glaucoma, Exfoliation glaucoma,Angle closure glaucoma 5)Refract value: Less than-9.0D,More than +9.0D 6)Patients whose intra ocular pressure can not be measured by iCare Tonometer 7)Patients with traumatic injury. 8)Patients with ocular inflammation of anterior segment. 9)Patients who can not be applied for photo slit. 10)Patients having a history of the operation during the past 6 months. 11)Users of contact lenses 12)Patients who are decided not be suitable for this trial by doctors.

发起方

Kochi medical school hospital,ophthalmology